Latest News and Press Releases

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025 ...

BOISE, Idaho, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 17, 2025,...

Agios today announced topline results from the 52-week double-blind period of the global RISE UP Phase 3 trial

OTTAWA, Ontario, 14 nov. 2025 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société de solutions essentielles axée sur la défense, l'espace, les soins de santé et d'autres secteurs...

Calian® Group Ltd., will hold a conference call at 8:30 a.m. Eastern Time on Wednesday, November 26, 2025, to discuss Q4 FY 2025 results.

KULR Technology Group, Inc. (NYSE American: KULR) November 18th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time)

Third quarter 2025 net revenues were $17.6 million Emrosi™ total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call...

Logistics revenue grew 3.3% year-over-year to $63.0 million, supported by continued US volume growthTrucking and Logistics delivered positive operating income for a second straight quarterOperating...

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a...

The Beauty Health Company reported third quarter financial results with Revenue and Adjusted EBITDA exceeding the top end of the guidance range.